Records containing: Rhematoid Arthritis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-21A Phase 1, Randomized, Double-blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JADE201 Administered Subcutaneously in Participants With Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2026-04-21A Prospective, Multi-Center Post-Market Clinical Study Evaluating the Safety, Performance, and Clinical Benefits of the Persona® SoluTion® PPS Femur
-
CLINICAL_TRIALS study record update · 2026-03-03Kinesiophobia in Rheumatoid Arthritis: Associations With Functional Disability, Disease Activity, and Related Clinical Factors
-
CLINICAL_TRIALS study record update · 2026-02-09Evaluation of CCR6 Gene Expression and Circulating CCL20 Levels as Potential Biomarkers in Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2026-02-05Pharmacogenetics of Leflunomide in the RA Management
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-29Rehabilitation Approaches Used by Physiotherapists Following Total Knee Replacement- a Cross-sectional Survey
-
CLINICAL_TRIALS study record update · 2025-12-02Very Low Dose, add-on Prednisolone in Patients With Newly Diagnosed Rheumatoid Arthritis: a Randomised Placebo-controlled Study
-
CLINICAL_TRIALS study record update · 2024-09-19Left Atrial Function and Dimensions As Predictors of Disease Activity in Rheumatoid Arthritis Patients
-
CLINICAL_TRIALS study record update · 2018-06-27A Phase 3b/4 Randomized Double Blind Study Of 5 Mg Of Tofacitinib With And Without Methotrexate In Comparison To Adalimumab With Methotrexate In Subjects With Moderately To Severely Active Rheumatoid Arthritis